$167.68
-0.08-0.05%
Pre-Market: 7:52 PM EDT
Comments
Loading...
Latest news for AbbVie (NYSE:ABBV) Stock
AbbVie Stock (NYSE: ABBV)
Categories: All
Wednesday, November 20, 2024
Monday, November 18, 2024
Sunday, November 17, 2024
Friday, November 15, 2024
Wednesday, November 13, 2024
Tuesday, November 12, 2024
- Citigroup Maintains Buy on AbbVie, Lowers Pri...
- AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
- Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
- BMO Capital Maintains Outperform on AbbVie, L...
- Navigating 14 Analyst Ratings For AbbVie
- Morgan Stanley Maintains Overweight on AbbVie...
Monday, November 11, 2024
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- What's Going On With Bristol-Myers Squibb Shares Monday?
- This Is What Whales Are Betting On AbbVie
- AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
- Live On CNBC, Jim Lebenthal Announces Bought ...
- AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
- AbbVie shares are trading lower after the com...
- AbbVie Reports Phase 2 EMPOWER Trials For Emr...
Friday, November 08, 2024
Wednesday, November 06, 2024
Monday, November 04, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
Wednesday, October 30, 2024
- Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
- Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
- AbbVie's Options Frenzy: What You Need to Know
- AbbVie shares are trading higher after the co...
- AbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth
- AbbVie Executive Says Company Cut 2024 U.S. H...
- AbbVie Executive Says Now Expect Skyrizi Glob...
- Abbvie Exec Says Company Now Seeing More Humi...
- AbbVie Raises Its Adjusted EPS Guidance For 2...
- AbbVie Q3 2024 Adj EPS $3.00 Beats $2.92 Esti...